Exploring converse molecular mechanisms of anti-HIV-1 antibodies using a synthetic CXCR4 mimic
Department of Chemistry and Pharmacy, University of Erlangen-Nürnberg, 91052 Erlangen, Germany. Bioorganic & medicinal chemistry letters
(Impact Factor: 2.42).
08/2012; 22(19):6099-102. DOI: 10.1016/j.bmcl.2012.08.035
Different molecular mechanisms of the two broadly neutralizing anti-HIV-1 antibodies b12 and VRC01, as evidenced by their converse effects on the interaction of HIV-1 envelope glycoprotein gp120 with cellular coreceptors, were demonstrated using a synthetic CXCR4 mimetic peptide (CX4-M1) as coreceptor surrogate. While the interaction of gp120 with CX4-M1 was distinctly enhanced by VRC01, b12 was shown to have the contrary effect, and also to inhibit the VRC01-induced enhancement of gp120 binding to the CXCR4 mimetic peptide.
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed. The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual current impact factor. Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence agreement may be applicable.